Investing Profile

Mike Dybbs

InvestorVC
Partner at Samsara BioCapital
samsaracap.com/mike-dybbs/Burlingame, California
Photo of Mike Dybbs, Partner at Samsara BioCapital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$10.0M - $100.0M
$25.0M
15
$310.1M
CompanyStageDateRound SizeTotal Raised
Arcellx
Series CApr 2021$120M
$120M
Ionpath
Series BSep 2020$18M
$18M
Co-investors: Jenny Rooke (Genoa Ventures)
Nkarta Therapeutics
Series BSep 2019$110M
$110M
Co-investors: Fouad Azzam (EQT Life Sciences)
Sutro Biopharma
Series EJul 2018$85M
$110M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds)
Principia Biopharma
Series BAug 2015$15M
Series BApr 2014$50M
Series AOct 2012$13M
$78M
Co-investors: Peter Thompson (OrbiMed), Simeon J. George (SR One), Nassim Usman (Morgenthaler Ventures)
Advanced Cell Diagnostics
Series CJun 2015$22M
Series BNov 2012$12M
$34M
Dimension Therapeutics
Series BApr 2015$65M
$65M
Versartis
Series EFeb 2014$55M
Series DOct 2013$20M
Series CJul 2013$12M
Series CJan 2013$25M
Series BFeb 2011$21M
$130M
Co-investors: Shahzad Malik (Advent Life Sciences)